hereditary thrombophilia

hereditary thrombophilia

(1) Antithrombin III deficiency. 
(2) Protein C deficiency.

hereditary thrombophilia

Hematology A hereditary ↑ tendency to form intravascular blood clots Etiology Factor V Leiden, prothrombin G20210A polymorphism, defects in homocysteine metabolism, protein C, protein S or antithrombin III. See LETS.
References in periodicals archive ?
Internationally, the publication of the European Prospective Cohort on Thrombophilia study in 1996 was among the first to provide evidence of a link between hereditary thrombophilia and recurrent miscarriages5.
The presence or absence of some of these variants is associated with an increased risk for developing any one of the following 10 diseases or conditions: Parkinson's disease, late-onset Alzheimer's disease; celiac disease, alpha-1 antitrypsin deficiency; early-onset primary dystonia; factor XI deficiency; Gaucher disease type 1; glucose-6-phosphate dehydrogenase deficiency; hereditary hemochromatosis; and hereditary thrombophilia.
The other diseases covered by the tests are celiac disease, alpha-1 antitrypsin deficiency, early onset primary dystonia, Factor XI deficiency, Gaucher disease type 1, glucose-6-Phosphate Dehydrogenase deficiency (also known as G6PD), hereditary hemochromatosis, and hereditary thrombophilia.
Genetics company 23andMe Inc reported on Thursday the receipt of the first authorisation from the the US Food and Drug Administration (FDA) to market genetic reports on personal risk for late-onset Alzheimer's disease, Parkinson's disease, celiac disease and hereditary thrombophilia (harmful blood clots), among others.
Hereditary thrombophilia is a group of genetic disorders of blood coagulation.
The factors which cause to arterial thrombosis in the neonatal period are examined in three main groups: 1) hereditary thrombophilia, 2) presence of prenatal risk factors (asphxia, diabetes in the mother, polystemia, sepsis, intravascular catheter applications), 3) syndromes with low cardiac output.
al: Hereditary Thrombophilia as a cause of Budd-Chiari Syndrome A study from western India; Hepatology 2001; 34: 666-670.
All included patients have been screened for thrombophilia all investigations were checked and patients with luteal phase defects infections represented namely by Mycoplasma and Chlamydia pathological levels for antinuclear factor or antiphospholipid antibodies (anticardiolipin IgG IgM antibodies or lupus anticoagulant) and with hereditary thrombophilia patterns protein C S and antithrombin deficiencies and presence of factor V Leiden mutation prothrombin (G20210A) mutation and homozygosity for MTHFR (C677T) were not included to study.
PGM is the most recent cause of hereditary thrombophilia to have had the genetic mutation elucidated.
Testing for hereditary thrombophilia in patients following a first episode of intra-abdominal thrombosis or cerebral sinus thrombosis does not clearly predict the risk of recurrence, and it does not provide evidence-based data on which to determine the duration of treatment.
2) Causes for hereditary thrombophilia result from single gene mutations, and include protein C deficiency, protein S deficiency, antithrombin deficiency, prothrombin mutation, and factor V Leiden.

Full browser ?